Lianya Pharmaceutical's application for an IPO on the Growth Enterprise Market has been approved.

On July 9, the Listing Committee of the Shenzhen Stock Exchange held the 41st listing review meeting of 2026. The review results showed that Nantong Lianya Pharmaceutical Co., Ltd. meets the requirements for initial public offering, listing, and information disclosure.